Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × Epirubicin × 90 days × Clear all

NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms